Literature DB >> 17021065

Comparison of mannitol salt agar and blood agar plates for identification and susceptibility testing of Staphylococcus aureus in specimens from cystic fibrosis patients.

Susan E Sharp1, Cindy Searcy.   

Abstract

Antimicrobial susceptibilities of Staphylococcus aureus strains can be determined accurately by using isolates from mannitol salt agar, and yellow isolates on mannitol salt agar at quantities of >1+ can be reported as S. aureus. These methods decrease the time to identification/antimicrobial susceptibility testing of S. aureus and decrease costs through eliminating additional testing.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17021065      PMCID： PMC1698434          DOI： 10.1128/JCM.01129-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  2 in total

Review 1.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

2.  Comparison of the BBL CHROMagar Staph aureus agar medium to conventional media for detection of Staphylococcus aureus in respiratory samples.

Authors:  Diane Flayhart; Clara Lema; Anita Borek; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948
  2 in total
  2 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Current pathogens infecting open fracture tibia and their antibiotic susceptibility at a tertiary care teaching hospital in South East Asia.

Authors:  Md Samiul Islam; Syed Shahidul Islam; Sultana Parvin; Mushfique Manjur; Muhammad Rafiqul Islam; Rabin Chandra Halder; Mohd Sayedul Islam; Syed Khaledur Rahaman; Mobinul Hoque; Md Omar Faruque; A K M Nazmul Haque
Journal:  Infect Prev Pract       Date:  2022-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.